Schizophrenia | Progress In Mind

Home

Congress highlights

Beyond the guidelines: Precision Medicine

Despite the attractiveness of precision medicine (PM) for providing personalized patient management...

Positive steps to address negative symptoms in schizophrenia

A goal of precision psychiatry is to locate a patient along the continuum of the disease course,...

Changing the course of schizophrenia: biology, psychology and livelihood

How to manage and mitigate some long-term problems associated with schizophrenia, and improve...

Refining and redefining diagnosis and prognosis in psychosis: can biomarkers and imaging help?

Consortia the world over are seeking biomarkers, including abnormalities on brain imaging, that...

Schizophrenia: more same than different to neurodevelopmental disorders?

Rather than a discrete entity, schizophrenia sits on a neurodevelopmental continuum of disorders...

Bipolar, Schizophrenia

Highlighted studies in psychosis

New light cast on links between mental illness and creativity; inflammatory pathways that may be...

Depression, Schizophrenia

Brain imaging: focus on predicting disease course and treatment response

Predicting disease course and predicting response to therapy – including the probability that...

Train, test, predict: Using big data and machine learning in psychiatry

Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine...

Congress highlights

Tackling the elephant in the room: non-adherence in schizophrenia

The challenges and consequences of non-adherence to treatment in schizophrenia, and some novel ways...

Congress highlights

Dopamine D2 partial agonists – efficacy, tolerability and improved functioning?

‘Functioning’ is a broad term, and encompasses the individual’s ability to...

Congress highlights

Dopamine D2 partial agonists – efficacy, tolerability and improved functioning?

‘Functioning’ is a broad term, and encompasses the individual’s ability to...

Treatment-resistant schizophrenia – results of a survey on its clinical impact and therapeutic strategies

The results of an online survey completed by 204 US psychiatrists on the clinical impact of...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind South East Asia
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in South East Asia click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline